Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO-Breast-Cancer-2021-1000x250

Satellite Symposia Resources from OncologyPRO sponsors

Find here all the resources from Industry Satellite Symposia published by our industry partners.

CDK4/6 inhibitors in early-stage HR+/HER2- breast cancer: Individualizing therapeutic decisions to improve patient outcomes

Clinical Care Options, supported by an educational grant from Lilly
Session Chair: Javier Cortés, Barcelona, Spain

ADCs for ABC: Antibody-drug conjugates for advanced/metastatic breast cancer

Daiichi-Sankyo / AstraZeneca
Session Chair: Eva Ciruelos, Madrid, Spain

Eribulin 10 years on: What is the role of eribulin in the contemporary management of mBC

Eisai Europe Ltd
Session Chair: Joyce O'Shaughnessy, Dallas, United States

Navigating a new clinical reality in advanced breast cancer: Treatment considerations in the real world

Pfizer Oncology
Session Chair: Guy Jerusalem, Liège, Belgium

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings